Quantum Genomics SA: Clinical Trials

2 trials sponsored by Quantum Genomics SA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow Quantum Genomics SA: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)
Firibastat (QGC001) Period 1 - Hypertension (HTN)
Phase 3TerminatedQuantum Genomics SA4192021-08-052023-01-17
Firibastat in Treatment-resistant Hypertension
Firibastat, Placebo - Hypertension
Phase 3CompletedQuantum Genomics SA5152020-06-252022-10-20

Conditions studied

Hypertension (2)

Interventions

firibastat (2)

Countries

United States (2)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

George Bakris, MD (1)

Results publications

PMID 33027067